Irene M. Ghobrial, Paul G. Richardson,
Kenneth C. Anderson
Editors

2011

The proteasome is a highly conserved multicatalytic protease that is responsible for cellular protein turnover, and several therapeutic agents have been developed that specifically target the proteasome. This truly targeted therapy has significantly altered the management of patients with Multiple Myeloma and improved survival.